T. Rowe Price Investment Management, Inc. Repare Therapeutics Inc. Transaction History

T. Rowe Price Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$8.16 - $13.01 $867,408 - $1.38 Million	-106,300 Reduced 5.59%	1,796,906 $21.7 Million
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $78,921 - $114,586	-9,145 Reduced 0.48%	1,903,206 $20.1 Million
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $52,891 - $85,465	-5,675 Reduced 0.3%	1,912,351 $18.8 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $1.94 Million - $2.82 Million	155,283 Added 8.81%	1,918,026 $28.2 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $20.4 Million - $27.5 Million	1,762,743 New	1,762,743 $21.4 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $118M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.